TARS
Tarsus Pharmaceuticals, Inc. Common Stock
stockNASDAQ
At CloseOct 23, 2026 3:59:58 PM EDT
68.13USD-5.480%(-3.95)556,620
Pre-marketOct 23, 2026 8:46:30 AM EDT
71.74USD-0.472%(-0.34)
TARS Financials
In Q2 FY 2026 (ended ), Tarsus Pharmaceuticals, Inc. Common Stock (TARS) reported revenue of $173.91M, net income of −$18.55M, operating cash flow of $61.22M, and assets of $611.14M.
Loading business breakdowns…